An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (52)
  • Training (0)
  • User case (2)
  • User meeting (1)
  • Webinar (4)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (4)
  • Breast (3)
  • Gastro-intestinal (7)
  • Genito-urinary (2)
  • Gynecological (0)
  • Head and neck (23)
  • Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (0)
  • Pediatric (1)
  • Reirradiation (1)
  • Sarcomas (0)
  • Thoracic (10)
  • Reset filters
  • (-) IMPT

The Model-based Approach

14/09/2022
/ Webinar
/
Model-based approach
IMPT

During ISOP 2022, Hans Langendijk presented the Model-based Approach. Watch the webinar above.

99% Uptime at Northwestern Medicine Chicago Proton Center

01/02/2019
/ Event
/
Proton therapy center
IMPT

The Northwestern Medicine Chicago Proton Center, the advanced cancer care center, has offered proton therapy treatments to patients using IBA’s Proteus®PLUS...

Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.

15/11/2022
/ Publications
/
IMPT
IMRT

Published in the Green Journal, the PTCOG lymphoma subcommittee conducted a systematic review on available dosimetric studies comparing IMPT free breathing (FB)...

High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.

15/11/2022
/ Publications
/
IMPT
IMRT

This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...

Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.

15/11/2022
/ Publications
/
IMPT
IMRT

163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...

Clinical experience from the first compact IMPT Proton Therapy Center: the advantages of treating in an open gantry environment

26/01/2018
/ Event
/
IMPT

The Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care...

Proton Therapy: DynamicARC vs IMPT Treatment Plans & Case Studies

12/07/2023
/ Webinar
/
ARC therapy
IMPT

This symposium held at the 2023 National Proton Conference covers the advantages of DynamicARC proton therapy treatment, and how it is sharper, faster, and...

Model-based for nasopharyngeal carcinoma

24/09/2020
/ Webinar
/
Model-based approach
VMAT
ARC therapy
IMRT
IMPT

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.

28/03/2024
/ Publications
/
IMPT
IMRT
Toxicity

This study reported the incidence of lymphopenia in 271 stage III NSCLC patients treated with IMPT (n=71) vs IMRT (n=200) and concurrent chemotherapy. The...

Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma.

08/04/2024
/ Publications
/
IMRT
IMPT

To compare the oncologic outcomes between proton therapy and intensity-modulated radiation therapy (IMRT) for head and neck squamous cell carcinoma (HNSCC)...

Pagination

  • Previous page ‹
    • Page 4
    • Current page 5
    • Page 6
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies